healthcare

healthcare Articles

Altimmune shares jumped on Wednesday after the company announced that the Biomedical Advanced Research and Development Authority is modifying its existing anthrax vaccine development contract with...
Tuesday was a breakout day for a few biotech companies that saw either huge gains or massive losses. 24/7 Wall St. has picked a few of those standouts to highlight.
Moderna shares jumped late on Monday after the firm announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for its investigational Zika vaccine (mRNA-1893)...
Vanda Pharma shares dropped early to start out the week after the frim announced that it received a Complete Response Letter from the FDA.
Akari Therapeutics shares jumped on Wednesday after the firm announced that the FDA has granted Fast Track designation for its stem cell transplant treatment.
Tilray released its second quarter financial results after the markets closed on Tuesday. The company said that it had a net loss of $0.36 per share and $45.9 million in revenue, compared with...
Eli Lilly shares made a handy gain on Tuesday after the firm announced results from its late-stage study for the treatment of moderate to severe plaque psoriasis.
Deciphera Pharma shares nearly doubled on Tuesday after the firm announced top-line results from its late-stage trial treating patients with gastrointestinal stromal tumors.
Tilray is scheduled to release its second-quarter financial results after the markets close on Tuesday, and analysts anticipate a net loss.
The July 31 short interest data have been compared with the previous figures, and short interest moves in these selected marijuana stocks were mixed.
The July 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Amarin shares dropped on Friday after the firm announced that it received notice from the FDA that delays a pending supplemental new drug application.
DBV Tech shares shot up on Thursday after the company announced the submission of paperwork to the FDA for Viaskin Peanut for the treatment of peanut-allergic children.
Rhythm Pharma shares jumped on Wednesday after the company announced positive results from two of its late-stage obesity clinical trials.